No photo available

Distinguished Professor Dietmar Hutmacher


  • Bio/Profile
  • Professor Hutmacher’s background is a strong combination of  academic  and industrial.  His expertise  is in biomaterials, biomechanics,  medical devices and tissue engineering.  He is one of the few academics  to take a  holistic bone engineering concept to clinical application.   More than 400 patients have been treated with  the FDA-approved bone  engineering scaffolds developed by Prof Hutmacher’s  Singapore-based  interdisciplinary research group. Over the last 4 years, Professor Hutmacher has developed an   international track record in adult stem cell research related to  regenerative  medicine. Regenerative  medicine/tissue engineering is a rapidly growing  multidisciplinary field  involving the life, physical and engineering  sciences and seeks to develop  functional cell, tissue and organ  substitutes to repair, replace or enhance  biological function that has  been lost due to congenital abnormalities, injury,  disease or aging. It  includes both the regeneration of tissues in vitro for  subsequent  implantation in vivo as well as regeneration directly in vivo. In   addition to having a therapeutic application, tissue engineering can  have a  diagnostic application where the engineered tissue is used as a  biosensor.  Engineered tissues can also be used for the development of  drugs including  screening for novel drug candidates, identifying novel  genes as drug targets,  and testing for drug metabolism, uptake, and  toxicity.